Floatz logo

plx038

Ependymoma

National Cancer Institute (NCI)Phase 1/2Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

35 Active assets in the Ependymoma cohort.

Asset / SponsorPhaseRating
Nivolumab
University of Florida
Phase 2BB
Olaparib
Fundación de investigación HM
Phase 2BB
Cyclophosphamide
Theodore S. Johnson
Phase 2B
Indoximod
Theodore S. Johnson
Phase 2B
ETOPOSIDE
Theodore S. Johnson
Phase 2B

View all 50 →

Same molecule, other indications

plx038 is also rated in:

fallopian tube carcinomaDormant
CCC
Indicative ·
50 / 100
View asset →
ovarian carcinomaDormant
CCC
Indicative ·
50 / 100
View asset →
primary peritoneal carcinomaDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →